- Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
[作者：Borchmann, P; Haverkamp, H; Diehl, V; Cerny, T; Markova, J; Ho, AD; Eich, HT; Mueller-Hermelink, HK; Kanz, L; Greil, R; Rank, A; Paulus, U; Smardova, L; Huber, C; Dorken, B; Nerl, C; Krause, SW; Mueller, RP; Fuchs, M; Engert, A,期刊：Journal of clinical oncology, 页码：4234-4242 , 文章类型： Article，,卷期：2011年29-32]
- Purpose Eight cycles of BEACOPP(escalated) (escalated dose of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) followed by radiotherapy (RT) to initial bulk or residual tumo...
- Case Report: Response to Ipilimumab in a Patient With HIV With Metastatic Melanoma
[作者：Burke, MM; Kluger, HM; Golden, M; Heller, KN; Hoos, A; Sznol, M,期刊：Journal of clinical oncology, 页码：E792-E794 , 文章类型： Article，,卷期：2011年29-32]
-
- Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer
[作者：Domchek, SM; Mitchell, G; Lindeman, GJ; Tung, NM; Balmana, J; Isakoff, SJ; Schmutzler, R; Audeh, MW; Loman, N; Scott, C; Friedlander, M; Kaufman, B; Garber, JE; Tutt, A; Robson, ME,期刊：Journal of clinical oncology, 页码：4224-4226 , 文章类型： Editorial Material，,卷期：2011年29-32]
-
- Frequency, Clinical Associations, and Longitudinal Course of Major Depressive Disorder in Adults With Cerebral Glioma
[作者：Rooney, AG; McNamara, S; Mackinnon, M; Fraser, M; Rampling, R; Carson, A; Grant, R,期刊：Journal of clinical oncology, 页码：4307-4312 , 文章类型： Article，,卷期：2011年29-32]
- Purpose There is a need for high-quality evidence regarding the frequency, independent clinical associations, and longitudinal course of depression in patients with cerebral glioma. Patients and Methods This was a twin-c...
- Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?
[作者：Jabbour, E; Kantarjian, HM; O'Brien, S; Shan, JQ; Quintas-Cardama, A; Garcia-Manero, G; Rios, MB; Cortes, JE,期刊：Journal of clinical oncology, 页码：4260-4265 , 文章类型： Article，,卷期：2011年29-32]
- Purpose The response definitions proposed by the European LeukemiaNet (ELN) are defined on the basis of imatinib front-line therapy. It is unknown whether these definitions apply to patients treated with second-generatio...
- Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study
[作者：Groen, HJM; Sietsma, H; Vincent, A; Hochstenbag, MMH; van Putten, JWG; van den Berg, A; Dalesio, O; Biesma, B; Smit, HJM; Termeer, A; Hiltermann, TJN; van den Borne, BEEM; Schramel, FMNH,期刊：Journal of clinical oncology, 页码：4320-4326 , 文章类型： Article，,卷期：2011年29-32]
- Purpose Cyclooxygenase-2 (COX-2) protein expression in patients with non-small-cell lung cancer (NSCLC) may be not only a prognostic marker but also predictive for COX-2 inhibition. We hypothesized that COX-2 expression ...
- RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
[作者：Brufsky, AM; Hurvitz, S; Perez, E; Swamy, R; Valero, V; O'Neill, V; Rugo, HS,期刊：Journal of clinical oncology, 页码：4286-4293 , 文章类型： Article，,卷期：2011年29-32]
- Purpose This phase III study compared the efficacy and safety of bevacizumab combined with standard chemotherapy regimens versus chemotherapy alone as second-line treatment of patients with human epidermal growth factor ...
- High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study
[作者：Dabbs, DJ; Klein, ME; Mohsin, SK; Tubbs, RR; Shuai, YL; Bhargava, R,期刊：Journal of clinical oncology, 页码：4279-4285 , 文章类型： Article，,卷期：2011年29-32]
- Purpose HER2 (ERBB2) status is an important prognostic and predictive marker in breast carcinoma. In recent years, Genomic Health (GHI), purveyors of the Oncotype DX test, has been separately reporting HER2 by reverse tr...
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
[作者：Chaturvedi, AK; Engels, EA; Pfeiffer, RM; Hernandez, BY; Xiao, WH; Kim, E; Jiang, B; Goodman, MT; Sibug-Saber, M; Cozen, W; Liu, LH; Lynch, CF; Wentzensen, N; Jordan, RC; Altekruse, S; Anderson, WF; Rosenberg, PS; Gillison, ML,期刊：Journal of clinical oncology, 页码：4294-4301 , 文章类型： Article，,卷期：2011年29-32]
- Purpose Recent increases in incidence and survival of oropharyngeal cancers in the United States have been attributed to human papillomavirus (HPV) infection, but empirical evidence is lacking. Patients and Methods HPV s...
|